1007125-06-5

Basic information

• Product Name: (1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate
• Synonyms: (1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate
• CAS NO: 1007125-06-5
• Molecular Formula: C₁₁H₁₇NO₅
• Molecular Weight: 243.25638
• Mol File: 1007125-06-5.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate(1007125-06-5)
• EPA Substance Registry System: (1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate(1007125-06-5)

Safety Data

• Hazardous Substances Data: 1007125-06-5(Hazardous Substances Data)

Usage

General Description

"(1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate" is a complex chemical compound with a bicyclic structure. It contains a tert-butyl group and a carboxylate group, along with multiple hydroxyl and oxo functional groups. The presence of the aza group indicates a nitrogen atom within the bicyclic structure. (1R,4S,5R,6S)-tert-butyl 5,6-dihydroxy-3-oxo-2-aza-bicyclo[2.2.1]heptane-2-carboxylate is likely a synthetic chemical with potential applications in pharmaceutical or chemical research due to its unique structure and functional groups. However, without additional context or specific research, its exact properties and potential uses are unclear.

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 79200-56-9 (-)-2-azabicyclo[2.2.1]hept-5-en-3-one 
• 200002-41-1 (-)-[(1R,4S)-tert-butyl 3-oxo-2-azabicyclo(2.2.1)hept-5-ene-2-carboxylate] 
• 49805-30-3 racemic 2-azabicyclo[2.2.1]hept-5-en-3-one 
• 151792-53-9 tert-butyl (1R,4S)-(-)-3-oxo-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylate 

Downstream Products

• 1007125-07-6 tert-butyl (1R,4S,5R,6S)-5,6-bis(benzoyloxy)-3-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate 
• 1208988-90-2 C₁₇H₁₉NO₅ 
• 1450975-28-6 (+)-(1R,2S,5R)-5-(hydroxymethyl)cyclopent-3-ene-1,2-diyl dibenzoate 
• 1007125-09-8 (-)-(1R,2S,3R,5R)-3-amino-5-(hydroxymethyl)cyclopentane-1,2-diyl dibenzoate hydrochloride 
• 1007125-08-7 (-)-(1R,2S,3R,5R)-3-((tert-butoxycarbonyl)amino)-5-(hydroxymethyl)cyclopentane-1,2-diyl dibenzoate 

Relevant articles and documents

RNAs Containing Carbocyclic Ribonucleotides

Toward the goal of evaluation of carbocyclic ribonucleoside-containing oligonucleotide therapeutics, we developed convenient, scalable syntheses of all four carbocyclic ribonucleotide phosphoramidites and the uridine solid-support building block. Crystall

Efficient and stereoselective synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA)

The invention provides a new convergent approach for the synthesis of 2′-fluoro-6′-methylene-carbocyclic adenosine (FMCA) from a readily available starting material (Vince lactam) in fourteen steps. An efficient and practical methodology for stereospecifi

Heteroaryl compounds useful as inhibitors of E1 activating enzymes

This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.